A recent study points to a specific immune protein, C3, that falls when people follow moderate calorie restriction and seems to play a role in age-related inflammation. In mice, blocking C3 reduced inflammatory signals that typically increase with age. This raises the possibility of treatments aimed at a single immune pathway to capture some benefits of calorie restriction while avoiding the physical and social burdens of strict dieting.
That possibility connects directly to human potential and inclusion: not everyone can or should undergo severe calorie restriction, so therapies that lower harmful inflammation could broaden who benefits from anti-aging advances. Follow the link to read how researchers tested C3 in animals and why this line of work could change the way we think about healthy aging, metabolism, and fair access to longevity-supporting care.
Moderate calorie restriction lowered an immune protein called C3 that appears to help drive chronic inflammation as the body ages. Blocking the same protein reduced age related inflammation in mice, raising the possibility that future treatments could mimic some benefits of calorie restriction without severe dieting.
